# What this table shows BL Research Bureau compiled a multi-column table of mutual fund scheme metrics as on Sep 05, 2026. For each listed scheme the table includes: BL rating, latest NAV (Rs.), latest corpus (Rs. crore), regular and direct expense ratios, 1-, 3-, 5- and 10-year CAGRs, and a Sortino ratio where available. Schemes across equity categories (large-cap, mid-cap, small-cap, flexi-cap, sectoral/thematic, ELSS), hybrid buckets and a few focused/thematic funds appear.
# Quick read on performance
- Strong 1-year positives: Bank of India Small Cap Fund at 27.0% and SBI Healthcare Opportunities Fund at 20.1%. Several Quant schemes also show double-digit 1-year gains (Quant Multi Asset Allocation 17.3%, Quant Small Cap 17.0%).
- Negative 1-year returns are visible in some thematic/sector funds: ICICI Prudential Technology Fund at -6.5% and Nippon India Consumption Fund at -7.7%.
Medium- to long-term (3-, 5-, 10-year) trajectories are mixed by category. Several mid- and small-cap schemes in the table show multi-year CAGRs in the high teens (for example, some mid-cap funds report 3- to 5-year CAGRs above 15%). Ten-year CAGRs are shown for a subset of funds and generally sit in the low- to mid-teens for many established large- and flexi-cap schemes.
# Costs and ratings Expense ratios for regular plans in the extract mostly fall between about 1.0% and 2.0%. Direct-plan expense ratios are typically around 0.4%–0.9% lower than the regular plan, consistent with the usual direct-vs-regular structure. BL ratings in the excerpt are primarily 5 and 4 for the schemes listed, which signals the table's internal quality assessment for these specific entries.
# Risk-adjusted measure shown
# How to use this information
# What the table does not do The published table is a factual snapshot. It does not offer portfolio holdings, turnover, style drift, or a forward view. For allocation decisions, pair these numbers with fund-specific documents (SIP volatility, portfolio composition, and manager tenure) before acting.
# Bottom line BL Research Bureau's table is a practical, compact source of scheme-level performance, cost and risk metrics as of Sep 05, 2026. It highlights how returns can diverge strongly across categories and themes in the short term, while fees and downside-adjusted metrics provide a useful lens for comparing net outcomes across similar funds.